A new chemical entity, perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile hydrate], has been listed in Schedule III, according to a Dec. 2, 2013, Federal Registernotice (78 Fed. Reg. 72013). On Oct. 22, 2012, the U.S. Food and Drug Administration approved a new drug application for perampanel as an adjunctive therapy for the treatment of partial ons... Read More